118 related articles for article (PubMed ID: 3092231)
1. Comparison of verapamil and nifedipine in thrombosis models.
Myers AK; Forman G; Torres Duarte AP; Penhos J; Ramwell P
Proc Soc Exp Biol Med; 1986 Oct; 183(1):86-91. PubMed ID: 3092231
[TBL] [Abstract][Full Text] [Related]
2. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
3. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Johnson GJ; Leis LA; Francis GS
Thromb Res; 1990 Jul; 59(1):139-48. PubMed ID: 2399526
[TBL] [Abstract][Full Text] [Related]
4. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
Lippton HL; Horwitz PM; McNamara DB; Landry AZ; Kadowitz PJ
Prostaglandins Leukot Med; 1984 Oct; 16(1):121-30. PubMed ID: 6440150
[TBL] [Abstract][Full Text] [Related]
5. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
6. Effect of Ca2+-antagonistic vasodilators, diltiazem, nifedipine, perhexiline and verapamil, on platelet aggregation in vitro.
Ono H; Kimura M
Arzneimittelforschung; 1981; 31(7):1131-4. PubMed ID: 7196762
[TBL] [Abstract][Full Text] [Related]
7. The antithrombogenic in vivo effects of calcium channel blockers in experimental thrombosis in mice.
Ortega MP; Sunkel C; Priego JG; Statkow PR
Thromb Haemost; 1987 Jun; 57(3):283-5. PubMed ID: 3660330
[TBL] [Abstract][Full Text] [Related]
8. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
Timar J; Chopra H; Rong X; Hatfield JS; Fligiel SE; Onoda JM; Taylor JD; Honn KV
J Cancer Res Clin Oncol; 1992; 118(6):425-34. PubMed ID: 1377695
[TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil, diltiazem and nifedipine on some parameters of hemostasis in the rat.
Pietraszek MH; Chabielska E; Buczko W
Thromb Res; 1988 Apr; 50(2):325-8. PubMed ID: 3394117
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
Kiyomoto A; Sasaki Y; Odawara A; Morita T
Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane in sudden death.
Myers AK; Ramwell PW
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():81-8. PubMed ID: 3159233
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.
Ware JA; Johnson PC; Smith M; Salzman EW
Circ Res; 1986 Jul; 59(1):39-42. PubMed ID: 3089642
[TBL] [Abstract][Full Text] [Related]
13. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Glusa E; Bevan J; Heptinstall S
Thromb Res; 1989 Jul; 55(2):239-245. PubMed ID: 2528843
[TBL] [Abstract][Full Text] [Related]
14. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
Vinge E; Andersson TL; Larsson B
Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
[TBL] [Abstract][Full Text] [Related]
15. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Beaughard M; Brasset M; John G; Massingham R
J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
Onoda JM; Nelson KK; Taylor JD; Honn KV
Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
19. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane.
McGoff MA; Allen BT; Der T; Sicard GA; Santoro SA
Thromb Res; 1989 Sep; 55(6):695-707. PubMed ID: 2506670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
